Karen Eubanks Jackson has reshaped the conversation around breast cancer for Black women in America—and now, with the ASCO ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, “significantly reduced” breast tissue cell growth, which is a major indicator of cancer ...

Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer survival disparities among racial and ethnic subgroups, particularly ...

A recent study reveals rising early-onset colorectal cancer rates, highlighting disparities and the need for improved ...

Adding immunotherapy to chemotherapy after surgery for stage 3 colon cancer may help decrease recurrence and death rate by 50 ...

A new FDA application for vepdegestrant offers hope for advanced breast cancer patients with ESR1 mutations, showcasing ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

New AI-driven applications launch seemingly every day, offering endless possibilities. AI can transform our immense body of ...

Patients who have completed colon cancer treatment could cut their risk of cancer-related death by 37% if they stick to a ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...